Crossmark

Genetic variants in m6A regulator genes confer susceptibility and progression of HCC in a Northern Chinese population

Crossref DOI link: https://doi.org/10.1007/s12672-025-02305-9

Published Online: 2025-04-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ji, Guohua

Gao, Cize

Yang, Yi

Ding, Yuli

Liu, Ruining

Wu, Shuang

Zhang, Xuelong

Liang, Xiao

Fu, Songbin

Cui, Xiaobo
Funding

Funding for this research was provided by:

Natural Science Foundation of Heilongjiang Province (No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007)

HMU Marshal Initiative Funding (No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007)
License Information

Text and Data Mining valid from 2025-04-15

Version of Record valid from 2025-04-15
More Information

Article History

Received: 18 December 2024

Accepted: 2 April 2025

First Online: 15 April 2025

Declarations

:

: All experimental procedures involving human subjects were reviewed and approved by the Ethics Committee of Harbin Medical University. This study was conducted in full compliance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to study enrollment, explicitly authorizing the use of their clinical data and biological specimens for scientific research purposes. This article does not contain any studies with animals performed by any of the authors.

: Informed consent was obtained from all subjects involved in the study.

: Consent for publication of this paper was obtained from all authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below